[
    [
        {
            "time": "",
            "original_text": "康泰生物(300601.SZ)拉升涨超9%两条新冠疫苗技术路线取得进展",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠疫苗",
                    "技术路线",
                    "进展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)拉升涨超9%两条新冠疫苗技术路线取得进展",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "创业板指涨超1%，康泰生物、阳光电源、宁德时代涨幅靠前",
            "features": {
                "keywords": [
                    "创业板指",
                    "康泰生物",
                    "阳光电源",
                    "宁德时代",
                    "涨幅靠前"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "新能源"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "创业板指涨超1%，康泰生物、阳光电源、宁德时代涨幅靠前",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物2月月报：寻业绩主线 重点关CXO等高增长赛道",
            "features": {
                "keywords": [
                    "医药生物",
                    "业绩主线",
                    "CXO",
                    "高增长赛道"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物2月月报：寻业绩主线 重点关CXO等高增长赛道",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]